NCT03887767

Brief Summary

Evaluation of the prognosis value of sST2 dosed before cardiac surgery on prognosis of long terme prognosis after cardiac surgery. The patients where initialy recruted for another cohort named micro-SIRS and inflammation but the gaved their consent to analyse the blood samples for other studies

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
158

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2019

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 25, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

March 25, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
Last Updated

March 10, 2020

Status Verified

March 1, 2020

Enrollment Period

8 months

First QC Date

March 5, 2019

Last Update Submit

March 9, 2020

Conditions

Cardiac Surgery

Outcome Measures

Primary Outcomes (1)

  • Mortality rate

    1 year mortality rate

    1 year

Secondary Outcomes (3)

  • Number of rehospitalisation

    1 day

  • Number of cardiac events

    1 day

  • Number of cardiac stroke

    1 day

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients included before cardiac surgery

You may qualify if:

  • Age between 18 and 80
  • cardiac surgery includind coronary arterial bypass of valvular surgery

You may not qualify if:

  • other surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

Study Officials

  • Kada KLOUCHE, MD PhD

    Hopital de Montpellier

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2019

First Posted

March 25, 2019

Study Start

March 25, 2019

Primary Completion

December 1, 2019

Study Completion

December 20, 2019

Last Updated

March 10, 2020

Record last verified: 2020-03

Locations

FR(1)